{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T23:31:02Z","timestamp":1780097462790,"version":"3.54.0"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Prostate Cancer TrueNTH","award":["250-55"],"award-info":[{"award-number":["250-55"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>To undertake a mixed-methodology implementation study to improve the well-being of men with gastrointestinal late effects following radical radiotherapy for prostate cancer. All men completed a validated screening tool for late bowel effects (ALERT-B) and the Gastrointestinal Symptom Rating Score (GSRS); men with a positive score on ALERT-B were offered management following a peer reviewed algorithm for pelvic radiation disease (PRD). Health-related quality of life (HRQoL) at baseline, 6 and 12 months; and healthcare resource usage (HRU) and patient, support-giver, staff experience and acceptability of staff training (qualitative analysis) were assessed. Two nurse- and one doctor-led gastroenterology services were set up in three UK cancer centres. Men (n = 339) who had had radical radiotherapy for prostate cancer at least 6 months previously, were recruited; of which 91\/339 were eligible to participate; 58\/91 men (63.7%) accepted the referral. Diagnoses included: radiation proctopathy (n = 18); bile acid malabsorption (n = 15); fructose or lactose intolerance and\/or small intestinal bacterial overgrowth (n = 20); vitamin B12\/D deficiency (n = 20). Increases in quality of life, sexual activity and\/or sexual function, and decrease in specific symptoms (e.g. bowel-related or urinary) between 6 and 12 months were observed. Limited HRU modelling suggested staff costs were \u00a3117-\u00a3185, depending on the service model; total costs averaged \u00a32,243 per patient. Both staff and patients welcomed the new service although there was concern about long-term funding and sustainability beyond the timeframe of the study (qualitative). PRD is increasingly recognised worldwide as an ongoing consequence of curative pelvic radiotherapy, despite widespread implementation of advanced radiotherapy techniques. Specialised services following national guidelines are required.<\/jats:p>","DOI":"10.1371\/journal.pone.0303356","type":"journal-article","created":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T18:30:31Z","timestamp":1738175431000},"page":"e0303356","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["The impact of specialised gastroenterology services for pelvic radiation disease (PRD): Results from the prospective multi-centre EAGLE study"],"prefix":"10.1371","volume":"20","author":[{"given":"John N.","family":"Staffurth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0253-1860","authenticated-orcid":true,"given":"Stephanie","family":"Sivell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elin","family":"Baddeley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Ahmedzai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Jervoise","family":"Andreyev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian J. J.","family":"Farnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Muls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"O\u2019Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Pickett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3116-5647","authenticated-orcid":true,"given":"Sophia","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annmarie","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,1,29]]},"reference":[{"issue":"10","key":"pone.0303356.ref001","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1046\/j.1365-2036.2003.01760.x","article-title":"How patients manage gastrointestinal symptoms after pelvic radiotherapy","volume":"18","author":"B Gami","year":"2003","journal-title":"Ailment Pharmacol Ther"},{"issue":"804\u2013818","key":"pone.0303356.ref002","article-title":"Prostate cancer: screening, diagnosis, and management","volume":"118","author":"M. Garnick","year":"1993","journal-title":"Ann Intern Med"},{"issue":"464\u2013469","key":"pone.0303356.ref003","article-title":"Systemic therapy for advancing or metastatic prostate cancer (STAMPEDE): a multi-arm, multistage randomized controlled trial","volume":"103","author":"N James","year":"2009","journal-title":"BJU Int"},{"issue":"8","key":"pone.0303356.ref004","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1136\/gut.2004.062596","article-title":"Gastrointestinal complications of pelvic radiotherapy: are they of any importance?","volume":"54","author":"J. Andreyev","year":"2005","journal-title":"Gut"},{"key":"pone.0303356.ref005","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/codi.12812","article-title":"Pelvic radiation disease","volume":"17","author":"HJN Andreyev","year":"2014","journal-title":"Colorectal Disease"},{"issue":"11","key":"pone.0303356.ref006","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S1470-2045(07)70341-8","article-title":"Gastrointestinal symptoms after pelvic radiotherapy: a new understanding to improve management of symptomatic patients","volume":"8","author":"J. Andreyev","year":"2007","journal-title":"Lancet Oncol"},{"issue":"1","key":"pone.0303356.ref007","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1470-2045(11)70293-5","article-title":"Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial","volume":"13","author":"D Dearnaley","year":"2012","journal-title":"Lancet Oncol"},{"issue":"10","key":"pone.0303356.ref008","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.clon.2007.08.011","article-title":"Gastrointestinal problems after pelvic radiotherapy: the past, the present and the future","volume":"19","author":"HJN Andreyev","year":"2007","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"8","key":"pone.0303356.ref009","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.clon.2011.04.002","article-title":"Late-onset bowel dysfunction after pelvic radiotherapy: a national survey of current practice and opinions of clinical oncologists","volume":"23","author":"CC Henson","year":"2011","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"7","key":"pone.0303356.ref010","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/bjc.2017.30","article-title":"Patients\u2019 perceptions of the negative effects following different prostate cancer treatments and the impact on psychological well-being: a nationwide survey","volume":"116","author":"U-S Lehto","year":"2017","journal-title":"Br J Cancer"},{"issue":"2","key":"pone.0303356.ref011","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.brachy.2016.11.002","article-title":"High-dose-rate brachytherapy monotherapy without androgen deprivation therapy for intermediate-risk prostate cancer","volume":"16","author":"S Patel","year":"2017","journal-title":"Brachytherapy"},{"issue":"1","key":"pone.0303356.ref012","doi-asserted-by":"crossref","DOI":"10.1111\/ecc.12589","article-title":"Factors associated with current and severe physical side-effects after prostate cancer treatment: What men report","volume":"27","author":"L Steentjes","year":"2018","journal-title":"Eur J Cancer Care (Engl)"},{"key":"pone.0303356.ref013","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s10552-020-01380-3","article-title":"Men\u2019s experiences of radiotherapy treatment for localized prostate cancer and its long-term treatment side effects: a longitudinal qualitative study","volume":"32","author":"E Sutton","year":"2021","journal-title":"Cancer Causes Control"},{"issue":"2","key":"pone.0303356.ref014","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/SPC.0000000000000422","article-title":"Methods of assessing late radiotherapy effects on bowel function","volume":"13","author":"A Nelson","year":"2019","journal-title":"Curr Opin Support Palliat Care"},{"issue":"6","key":"pone.0303356.ref015","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.clon.2018.01.016","article-title":"Older age, early symptoms and physical function are associated with the severity of late symptom clusters for men undergoing radiotheraoy for prostate cancer","volume":"30","author":"A Lemsanska","year":"2018","journal-title":"Clinical Oncology"},{"issue":"10","key":"pone.0303356.ref016","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/S1470-2045(22)00517-4","article-title":"Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial","volume":"23","author":"AC Tree","year":"2022","journal-title":"The Lancet Oncology"},{"issue":"12","key":"pone.0303356.ref017","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1007\/s11547-023-01705-7","article-title":"Locally advanced cervical cancer: how the imporvement in techniques in external beam radiotherapy and brachytherapy impacts on survival outcomes and long-term toxicities","volume":"128","author":"F Barbera","year":"2003","journal-title":"Radiol Med"},{"issue":"2","key":"pone.0303356.ref018","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/jrr\/rrw098","article-title":"A retrospective comparison of outcome and toxicity of preoperative image\u2014guided intensity\u2014modulated radiotherapy versus conventional pelvic radiotherapy for locally advanced rectal carcinoma","volume":"58","author":"C-M Huang","year":"2017","journal-title":"Journal of Radiation Research"},{"key":"pone.0303356.ref019","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/s00520-020-05402-3","article-title":"Bowel dysfunction in survivors of gynaecologic malignancies","volume":"28","author":"Y Ribas","year":"2020","journal-title":"Supportive Care in Cancer"},{"issue":"13","key":"pone.0303356.ref020","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1158\/1078-0432.CCR-19-2744","article-title":"Long-term consequences of pelvic irradiation: toxicities, challenges, and therapeutic opportunities with pharmacologic mitigators","volume":"26","author":"JW Huh","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"48","key":"pone.0303356.ref021","doi-asserted-by":"crossref","first-page":"7289","DOI":"10.3748\/wjg.14.7289","article-title":"Recent advances in the management of radiation colitis","volume":"14","author":"J Kountouras","year":"2008","journal-title":"World J Gastroenterol"},{"key":"pone.0303356.ref022","doi-asserted-by":"crossref","first-page":"4881","DOI":"10.1007\/s00520-020-05309-z","article-title":"A proposed tailored investigational algorithm for women treated for gynaecological cancer with long-term gastrointestinal consequences","volume":"28","author":"A Muls","year":"2020","journal-title":"Supportive Care in Cancer"},{"issue":"6B","key":"pone.0303356.ref023","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1111\/bju.13122","article-title":"Symptoms, unmet needs, psycbilogical well-being and health status in survivors of prostate cancer: implications for redesigning follow-up","volume":"117","author":"E Watson","year":"2016","journal-title":"BJU International"},{"key":"pone.0303356.ref024","doi-asserted-by":"crossref","first-page":"e011773","DOI":"10.1136\/bmjopen-2016-011773","article-title":"Improving the well-being of men by Evaluating and Addressing the Gastrointestinal Late Effects (EAGLE) of radical treatment for prostate cancer: study protocol for a mixed-method implementation project","volume":"6","author":"S Taylor","year":"2016","journal-title":"BMJ Open"},{"key":"pone.0303356.ref025","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1748-5908-4-29","article-title":"Development of a theory of implementation and integration","volume":"4","author":"C May","year":"2009","journal-title":"Normalization Process Theory. Implement Sci"},{"issue":"1","key":"pone.0303356.ref026","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1741-7015-8-63","article-title":"Normalisation process theory: a framework for developing, evaluating and implementing complex interventions","volume":"8","author":"E Murray","year":"2010","journal-title":"BMC Med"},{"issue":"10","key":"pone.0303356.ref027","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1016\/j.clon.2016.06.004","article-title":"The Three-item ALERT-B Questionnaire Provides a Validated Screening Tool to Detect Chronic Gastrointestinal Symptoms after Pelvic Radiotherapy in Cancer Survivors","volume":"28","author":"S Taylor","year":"2016","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"21","key":"pone.0303356.ref028","first-page":"98","article-title":"The ALERT-B questionnaire: A screening tool for the detection of gastroenterological late effects after radiotherapy for prostate cancer","volume":"4","author":"D Farnell","year":"2020","journal-title":"Clin Transl Radiat Oncol"},{"issue":"1","key":"pone.0303356.ref029","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1136\/flgastro-2014-100468","article-title":"Guidance: The practical management of the gastrointestinal symptims of pelvic radiation disease","volume":"6","author":"HJN Andreyev","year":"2015","journal-title":"Frontline Gastroenterol"},{"key":"pone.0303356.ref030","doi-asserted-by":"crossref","first-page":"305","DOI":"10.4135\/9781412986274.n12","volume-title":"The Qualitative Researcher\u2019s Companion","author":"J Ritchie","year":"2002"},{"key":"pone.0303356.ref031","volume-title":"Qualitative Research Practice: A Guide for Social Science Students and Researchers","author":"J LJ Ritchie","year":"2013"},{"key":"pone.0303356.ref032","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s10464-012-9522-x","article-title":"The quality implementation framework: a synthesis of critical steps in the implementation process","volume":"50","author":"DC Meyers","year":"2012","journal-title":"Am J Community Psychol"},{"issue":"8","key":"pone.0303356.ref033","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1007\/s00520-013-1782-y","article-title":"Structured gastroenterological intervention and improved outcome for patients with chronic gastrointestinal symptoms following pelvic radiotherapy","volume":"21","author":"CC Henson","year":"2013","journal-title":"Support Care Cancer"},{"issue":"241\u2013249","key":"pone.0303356.ref034","article-title":"Gastroenterologist and nurse management of symptoms after pelvic radiotherapy for cancer: an economic evaluation of a clinical randomized controlled trial (the ORBIT study)","volume":"28","author":"J Jordan","year":"2017","journal-title":"Clinicoecon Outcomes Res"},{"key":"pone.0303356.ref035","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.12968\/bjon.2017.26.4.S15","article-title":"Late gastrointestinal effects of pelvic radiation: a nurse-led service","volume":"26","author":"H Ludlow","year":"2017","journal-title":"British Journal of Nursing"},{"issue":"2084\u20132092","key":"pone.0303356.ref036","article-title":"Algorithm-based management of patients with gastrointestinal symptoms in patients after pelvic radiation treatment (ORBIT): a randomised controlled trial","volume":"382","author":"HJN Andreyev","year":"2013","journal-title":"Lancet"},{"issue":"240\u2013246","key":"pone.0303356.ref037","article-title":"The holistic management of consequences of cancer treatment by a gastrointestinal and nutrition team: a financially viable approach to an enormous problem?","volume":"16","author":"AC Muls","year":"2016","journal-title":"Clin Med (Lond)"},{"issue":"8","key":"pone.0303356.ref038","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.clon.2011.03.006","article-title":"Can nurses manage gastrointestinal symptoms arising from pelvic radiation disease?","volume":"23","author":"B Benton","year":"2011","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"30\u201334","key":"pone.0303356.ref039","article-title":"Gastrointestinal symptoms of pelvic radiation disease (part 4): professional awareness and specialist support","volume":"18","author":"H Ludlow","year":"2020","journal-title":"Gastrointestinal Nursing"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0303356","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T18:30:53Z","timestamp":1738175453000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0303356"}},"subtitle":[],"editor":[{"given":"Bruno","family":"Fionda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,1,29]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0303356","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,29]]}}}